This information is intended for US health care professionals only.
/
The Great MS Debate: What does the evidence say about using a high-efficacy treatment approach sooner?
Amit Bar-Or, MD, FRCP, FAAN, FAN; James Stankiewicz, MD; Fred Lublin, MD; Claire Riley, MD; Timothy Vartanian, MD, PhD
Panelists review the available evidence for using high-efficacy treatment earlier in a patient's disease course
VIDEO (16 MIN)
The Great MS Debate: What are patients and healthcare providers looking for?
Panelists engage in a reflective discussion around how patient preferences play in the shared decision-making process
VIDEO (10 MIN)
Back to Partners in Care
Use of this website is governed by the Terms of Use and Privacy Policy.
Copyright © 2024 Novartis Pharmaceuticals Corporation. All rights reserved.
1/24
381461
The content you are trying to reach requires an account. Please log in or register to gain access.